Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia
Study Information
Alliance Study ID: NCCTG-989251
NCT Study ID (ClinicalTrials.gov): NCT00031759
Alliance Committee: Cancer Control
Disease or Cancer Type: Gynecologic Cancers – Ovarian / Uterine / Cervical / Endometrial
Alliance Study Chair: Bobbie S. Gostout, MD
Status: COMPLETED
Study Description
RATIONALE: Chemoprevention therapy is the use of certain substances to try to prevent the development of cancer. Applying topical imiquimod before abnormal cervical cells are removed may be effective in preventing cervical cancer.
PURPOSE: Randomized phase II trial to study the effectiveness of applying topical imiquimod before abnormal cervical cells are removed in preventing cervical cancer in patients who have recurrent or persistent cervical neoplasia.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information